MIR4491: A Potential Drug Target and Biomarker for Obesity (G100616330)
MIR4491: A Potential Drug Target and Biomarker for Obesity
Obesity has become a significant public health issue in recent years, with an estimated 285 million people worldwide classified as obese. This condition not only affects the physical health but also has a significant impact on mental health and social wellbeing. The rising prevalence of obesity has led to an increased demand for effective weight loss treatments. MIR4491, a nuclear translocation gene, has been identified as a potential drug target and biomarker for obesity.
MIR4491 is a non-coding RNA molecule that is located in the mouse oblique layer. It is a key regulator of the thermorRegulated gene expression (TREBP), which is involved in the control of energy metabolism and body temperature. MIR4491 functions as a negative regulator of TREBP, which means that when TREBP is activated, MIR4491 is in a downregulated state, and when TREBP is deactivated, MIR4491 is transcribed and translated into protein.
The oblique layer is a unique layer of the mouse embryo that is involved in the development of the nervous system, and its loss is associated with various neurological disorders. MIR4491 is located in this layer and is involved in the regulation of neuronal excitability and synaptic plasticity. The loss of oblique layer cells has been linked to the development of various neurological disorders, including obesity.
MIR4491 is a potential drug target for obesity because of its involvement in the regulation of energy metabolism and body temperature. Excessive energy intake can lead to an increase in body temperature, which can contribute to the development of obesity. MIR4491 plays a role in regulating the activity of enzymes involved in energy metabolism, such as the citrate synthase and the electron transport chain. By modulating the activity of these enzymes, MIR4491 can influence the body's energy homeostasis and contribute to the development of obesity.
MIR4491 is also a potential biomarker for obesity. The identification of MIR4491 as a potential drug target and biomarker for obesity has implications for the development of obese treatment strategies. By targeting MIR4491 with drugs, researchers hope to reduce the absorption of food into the body and improve energy metabolism, leading to weight loss. Additionally, MIR4491's involvement in the regulation of neuronal excitability and synaptic plasticity makes it an attractive target for the development of anti-obesity drugs that target this pathway.
In conclusion, MIR4491 is a potential drug target and biomarker for obesity. Its involvement in the regulation of energy metabolism and body temperature makes it an attractive target for the development of obese treatment strategies. Furthermore, MIR4491's involvement in the regulation of neuronal excitability and synaptic plasticity makes it a promising target for the development of anti-obesity drugs. Further research is needed to fully understand the role of MIR4491 in the development of obesity and to develop effective obese treatment strategies.
Protein Name: MicroRNA 4491
The "MIR4491 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4491 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675
